Reumafen - Pharmacology: Decreases inflammation, pain, and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.
Indication: Relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. Relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis (JRA) in patients 2 yr of age and older.
Unlabeled Uses
Treatment of ankylosing spondylitis, pain, and acute shoulder pain.
Reumafen is an nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Prostaglandins are substances that contribute to inflammation of joints. Reumafen inhibits prostaglandin synthetase (cylooxygenase 1 and 2) and leads to a decrease of the synthesis of prostaglandins, therefore, inflammation is reduced.
Oral Rheumatoid arthritis
Adult: 15 mg daily as a single dose. Patients with increased risk of adverse effects: Initially 7.5 mg.
Elderly: 7.5 mg daily for long-term treatment. Oral Ankylosing spondylitis
Adult: 15 mg daily as a single dose. Patients with increased risk of adverse effects: Initially 7.5 mg.
Elderly: 7.5 mg daily for long-term treatment. Oral Acute exacerbations of osteoarthritis
Adult: 7.5 mg daily up to a max of 15 mg as a single dose.
Elderly: 7.5 mg daily. Oral Juvenile rheumatoid arthritis
Child: ≥2 yr: 125 mcg/kg ocne daily. Max dose: 7.5 mg daily. Rectal Ankylosing spondylitis
Adult: 15 mg daily as a single dose. Patient with increased risk of adverse effects: Initially 7.5 mg. Limit use to the shortest time possible.
Elderly: 7.5 mg daily. Limit use to the shortest time possible. Rectal Rheumatoid arthritis
Adult: 15 mg daily as a single dose. Patient with increased risk of adverse effects: Initially 7.5 mg. Limit use to the shortest time possible.
Elderly: 7.5 mg daily. Limit use to the shortest time possible. Rectal Acute exacerbations of osteoarthritis
Adult: 7.5 mg daily up to a max of 15 mg daily as a single dose. Limit use to the shortest time possible.
Elderly: 7.5 mg daily. Limit use to the shortest time possible.
Reumafen helps relieve pain and inflammation.
Reumafen (Danapha) helps relieve pain and inflammation.
Oral Rheumatoid arthritis
Adult: 15 mg daily as a single dose. Patients with increased risk of adverse effects: Initially 7.5 mg.
Elderly: 7.5 mg daily for long-term treatment. Oral Ankylosing spondylitis
Adult: 15 mg daily as a single dose. Patients with increased risk of adverse effects: Initially 7.5 mg.
Elderly: 7.5 mg daily for long-term treatment. Oral Acute exacerbations of osteoarthritis
Adult: 7.5 mg daily up to a max of 15 mg as a single dose.
Elderly: 7.5 mg daily. Oral Juvenile rheumatoid arthritis
Child: ≥2 yr: 125 mcg/kg ocne daily. Max dose: 7.5 mg daily. Rectal Ankylosing spondylitis
Adult: 15 mg daily as a single dose. Patient with increased risk of adverse effects: Initially 7.5 mg. Limit use to the shortest time possible.
Elderly: 7.5 mg daily. Limit use to the shortest time possible. Rectal Rheumatoid arthritis
Adult: 15 mg daily as a single dose. Patient with increased risk of adverse effects: Initially 7.5 mg. Limit use to the shortest time possible.
Elderly: 7.5 mg daily. Limit use to the shortest time possible. Rectal Acute exacerbations of osteoarthritis
Adult: 7.5 mg daily up to a max of 15 mg daily as a single dose. Limit use to the shortest time possible.
Elderly: 7.5 mg daily. Limit use to the shortest time possible. Special Populations: In patients with an increased risk of adverse reactions: Initially, 7.5 mg daily. Dialysis patients: Max daily dose of 7.5 mg.
Indications:
Adult: PO/Rectal Ankylosing spondylitis ; Rheumatoid arthritis 15 mg once daily. Patients w/ increased risk of adverse effects: Initial: 7.5 mg. Acute exacerbations of osteoarthritis 7.5 mg once daily. Max: 15 mg once daily.
Mexicam is used for its anti-inflammatory and analgesic effects in the symptomatic treatment of acute and chronic rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Gouty arthritisSevere pain of any origin |
brands or generic drugs
